CVS Health CVS shares have rallied nearly 38% so far this month, driven by the company’s stronger-than-expected first-quarter ...

UnitedHealth Group announced Tuesday that CEO Andrew Witty is stepping down for “personal reasons,” with the company providing no further details on the abrupt departure. Former CEO Stephen Hemsley, ...

UnitedHealth Group earlier Tuesday suspended its earnings guidance for 2025, prompting investors to pull back on shares of the company and other names in the healthcare space.

CVS Health Corporation CVS and The Cigna Group CI shares trading lower Tuesday. President Donald Trump on Monday signed an ...

Witty will act as a senior advisor to his successor, Stephen Hemsley, who served as UnitedHealth Group’s CEO from 2006 to ...

Cigna’s stock slipped over 5% on a day the S&P 500 soared, thanks to a bold move by President Trump targeting pharmacy ...

The market reaction came as Trump signed a wide-ranging executive order aimed at slashing prescription drug prices in the US.

Key Takeaways The S&P 500 rose 3.3% on Monday, May 12, 2025, as investors reviewed a trade deal between the U.S. and China ...

President Donald Trump on Monday delivered a blow to the private-sector middlemen who negotiate U.S. drug prices in his ...

Stock indexes settle moderately higher on Thursday ... although that was stronger than expectations of a larger decline to 47.9. The Apr ISM prices paid sub-index rose +0.4 to a 2-3/4 year high of ...

The decline was mainly caused by a massive surge in imports, as buyers rushed to get ahead of new tariffs, and a fall in government spending. When imports far outweigh exports, it drags down ...

CVS HEALTH CORP (CVS) is a large-cap growth stock in the Retail (Drugs) industry. The rating using this strategy is 81% based on the firm’s underlying fundamentals and the stock’s valuation.